Gender effects on plasma PGRN levels in patients with Alzheimer's disease: A preliminary study

Journal of Alzheimer's Disease

Volumn 35, Issue 2, 2013, Pages 313-318

  Piscopo, Paola ^a   Rivabene, Roberto ^a   Galimberti, Daniela ^b   Crestini, Alessio ^a   Talarico, Giuseppina ^c   Vanacore, Nicola ^a   Scarpini, Elio ^b   Bruno, Giuseppe ^c   Confaloni, Annamaria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; gender; plasma; progranulin

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA; PROGRANULIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DSM-IV; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

EID: 84877145860     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121606     Document Type: Article

References (34)

1. Piscopo P, Rivabene R, Adduci A, Mallozzi C, Malvezzi-Campeggi L, Crestini A, ConfaloniA(2010) Hypoxia induces up-regulation of progranulin in neuroblastoma cell lines. Neurochem Int 57, 893-898
2. TohH, Chitramuthu BP, BennettHP, BatemanA(2011) Structure, function, and mechanism of progranulin; the brain and beyond. J Mol Neurosci 45, 538-548
3. Suzuki M, Nishiahara M (2002) Granulin precursor gene: A sex steroid-inducible gene involved in sexual differentiation of the rat brain. Mol Genet Metab 75, 31-37
4. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R,McGowan E,Mann D, Boeve B, Feldman H, HuttonM(2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442, 916-919
5. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ, van Duijn C, Peeters K, Sciot R, Santens P, De Pooter T, Mattheijssens M, Van den Broeck M, Cuijt I, Vennekens K, De Deyn PP, Kumar-Singh S, Van Broeckhoven C (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442, 920-924
6. Van Swieten JC, Heutink P (2008) Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 7, 965-974
7. Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F, Venturelli E, Restelli I, Cantoni C, Bresolin N, Monaco F, Scarpini E, Galimberti D (2009) Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic mild cognitive impairment converted to Alzheimer's disease. J Neurol Sci 287, 291-293
8. Marcon G, Rossi G, Giaccone G, Giovagnoli AR, Piccoli E, Zanini S, Geatti O, Toso V, Grisoli M, Tagliavini F (2011) Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene. J Alzheimers Dis 26, 583-590
9. Antonell A, Gil S, Śanchez-Valle R, Balasa M, Bosch B, Prat MC, Chiollaz AC, Ferńandez M, Yagüe J, Molinuevo JL, Llad́o A (2012) Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: Detection of GRN. Mutations in a Spanish cohort. J Alzheimers Dis 31, 581-591
10. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, BucklesV, OliverA,Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC, The Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367, 795-804
11. Craig-Schapiro R, Fagan AM, Holtzman DM (2009) Biomarkers of Alzheimer's disease. Neurobiol Dis 35, 128-140
12. Ghidoni R, Stoppani E, Rossi G, Piccoli E, Albertini V, Paterlini A, Glionna M, Pegoiani E, Agnati LF, Fenoglio C, Scarpini E, Galimberti D, Morbin M, Tagliavini F, Binetti G, Benussi L (2012) Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: A multicenter Italian study. Neurodegener Dis 9, 121-127
13. Fenoglio C, Galimberti D, Cortini F, Kauwe JSK, Cruchaga C, Venturelli E, Villa C, Serpente M, Scalabrini D, Mayo K, PiccioLM,Clerici F, Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Scarpini E (2009) Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease. J Alzheimers Dis 18, 603-612
14. Hsiung GY, Fok A, Feldman HH, Rademakers R, Mackenzie IR (2011) rs5848 polymorphism and serum progranulin level. J Neurol Sci 300, 28-32
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
16. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198
17. Folstein M (1984) Alzheimer's disease: Challenge to psychiatry. Hosp Community Psychiatry 35, 111
18. Cortini F, Fenoglio C, Guidi I, Venturelli E, Pomati S, Marcone A, Scalabrini D,Villa C, Clerici F, DallaValle E, Mariani C, Cappa S, Bresolin N, Scarpini E, Galimberti D (2008) Novel exon 1 progranulin gene variant in Alzheimer's disease. Eur J Neurol 15, 1111-1117
19. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, Wszolek Z, Gonzalez J, Beach TG, Bigio E, Johnson N, Weintraub S, Mesulam M, White CL 3rd,Woodruff B, Caselli R, Hsiung GY, Feldman H, Knopman D, Hutton M, Rademakers R (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15, 2988-3001
20. Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A (2006) Genetic study of Sardinian patients with Alzheimer's disease. Neurosci Lett 398, 124-128
21. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, Rademakers R (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132(Pt 3), 583-591
22. Gambassi G, Lapane KL, Landi F, Sgadari A, MorV, Bernabie R (1999) Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. Neurology 53, 508-516
23. Azad NA, Al Bugami M, Loy-English I (2007) Gender differences in dementia risk factors. Gender Med 4, 120-129
24. Cahill L (2006) Why sex matters for neuroscience. Nat Rev Neurosci 7, 477-484
25. Bao AM, Meynen G, Swaab DF (2008) The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Res Rev 57, 531-553
26. Sherwin BB (2002) Estrogen and cognitive aging in women. Trends Pharmacol Sci 23, 527-534
27. BrintonRD(2004) Impact of estrogen therapy on Alzheimer's disease: A fork in the road? CNS Drugs 18, 405-422
28. Pike CJ, Carroll JC, Rosario ER, BarronAM(2009) Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol 30, 239-258
29. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R (2005) Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A 102, 19198-19203
30. Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ (2011) Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging 32, 604-613
31. Suzuki M, Yonezawa T, Fujioka H, Matuamuro M, Nishihara M (2001) Induction of granulin precursor gene expression by estrogen treatment in neonatal rat hypothalamus. Neurosci Lett 297, 199-202
32. Suzuki M,Yoshida S, Nishihara M, TakahashiM(1998) Identification of a sex steroid-inducible gene in the neonatal rat hypothalamus. Neurosci Lett 242, 127-130
33. Suzuki M, Lee HC, Kayasuga Y, Chiba S, Nedachi T, Matsuwaki T, Yamanouchi K, Nishihara M (2009) Roles of progranulin in sexual differentiation of the developing brain and adult neurogenesis. J Reprod Dev 55, 351-355
34. MacGowan SH, Wilcock GK, Scott M (1998) Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease. Int J Geriatr Psychiatry 13, 625-630